Your desired caffeine level. Your additives precisely added.
Every cup — any time of day.
That's Coffee Without a Curfew.
You want a coffee at 3 PM. You know what happens if you do — a disrupted night, lost productivity the next morning. So you skip it. And lose the afternoon anyway.
This is the daily calculation of hundreds of millions of people who love coffee but can't control what comes with it. The solution isn't decaf. The solution is the right amount of caffeine, chosen by you, before you brew. No one has built that. Until now.
The global premium coffee appliance market is accelerating — and it has a precision-shaped hole in the middle of it that no patent, no product, and no brand has addressed.
Every brand above has engineered faster extraction, smarter grinders, and sleeker form factors. Not one of them lets you choose how much caffeine is in your cup.
Full technical documentation, system architecture, tier specifications, and licensing terms are available to verified parties only. Tell us who you are — we review every request personally.
Upon approval you'll receive a private access link to the full Caffevolve™ technology portal.
All submissions are reviewed personally by our team within 48 hours.
Mutual NDA available upon request.
Caffevolve™ Corporation · Patent Pending · Application No. 63/975,562
Thank you. We'll review your request and follow up within 48 hours.
— The Caffevolve™ Team
Your private access code was sent following approval of your request.
Please review and sign the Caffevolve™ Mutual NDA to access the full technology portal.
This Agreement is entered into by and between Caffevolve™ Corporation, 3412 56th Ave, Kenosha, WI 53144 ("Caffevolve") and the undersigned Receiving Party.
Includes all non-public information: patent applications, engineering specs, technical drawings, business plans, financial data, licensing strategies, product concepts, and any information a reasonable person would consider confidential. Excludes info already public, previously known, or independently developed.
Receiving Party shall hold Confidential Information in strict confidence; not disclose to third parties without written consent; use only for evaluating a potential business relationship; and protect with at least the same degree of care as its own confidential information (no less than reasonable care).
Receiving Party acknowledges Caffevolve's technology is subject to pending USPTO patent applications. This Agreement grants no rights in any patent. Receiving Party shall not reverse engineer or file any patent application based on Caffevolve's Confidential Information. During the term and two (2) years after termination, Receiving Party shall not develop substantially similar or competitive technology using Caffevolve's Confidential Information.
All work product conceived in connection with the Technology is the sole property of Caffevolve. Receiving Party irrevocably assigns all right, title, and interest therein to Caffevolve, including all intellectual property rights.
Upon request or termination, Receiving Party shall return or permanently destroy all Confidential Information and certify compliance in writing.
Effective for three (3) years. Confidentiality obligations survive for five (5) years post-termination; indefinitely for trade secrets.
Breach may cause irreparable harm. Caffevolve is entitled to seek injunctive relief without posting bond. Prevailing party in litigation recovers attorneys' fees.
Governed by Wisconsin law. Disputes subject to exclusive jurisdiction of courts in Kenosha County, Wisconsin.
Nothing herein obligates either party to enter any further agreement or transaction.
By signing, Receiving Party agrees to be bound by all terms of the Caffevolve™ Mutual Non-Disclosure Agreement.
Patent-Pending Brewing Technology
Tailored. Enhanced. Any time of day.
A breakthrough dual-hopper brewing platform built for the world's leading appliance manufacturers — enabling precise caffeine customization without compromising flavor.
The Opportunity
Millions of coffee drinkers love the ritual and flavor of coffee — but stop drinking it after noon. The reason isn't the taste. It's the caffeine. Sleep anxiety, sensitivity, and evening routines force consumers to choose between the coffee they love and the sleep they need.
No existing home brewing system gives consumers precise, real-time control over caffeine content while preserving the full-spectrum flavor they expect from premium coffee. Until now.
Core Innovation
Caffevolve's patent-pending system uses two independent bean hoppers — one caffeinated, one decaffeinated — to blend beans in precise proportions before grinding. The result: consistent flavor at any caffeine level from 0% to 100%, combined with an integrated additive dispensing system for wellness supplements.
Caffevolve™ Advancara — Patent Technical Drawing
Live Interactive Demonstrations
Eight fully interactive models demonstrating the core Caffevolve™ technology — how it works mechanically, the science behind why it matters, and the business case for licensing partners.
The Advancara touchscreen UI demonstrates the full consumer experience — from brew customization to additive selection, saved user profiles, and cartridge management.
This mockup is built to spec and reflects the actual user flow patent documentation, serving as a concrete visual for licensing discussions with appliance manufacturers.
Product Portfolio
Business Model
Patent-pending blend-then-grind technology, system architecture, and additive platform. Provisional patent filed February 4, 2026.
Partners like Breville, Fellow, and Ninja manufacture and distribute under their brand, incorporating Caffevolve's technology under license.
Per-unit royalty on every product sold. No manufacturing overhead, no supply chain risk, no distribution complexity.
Why This Model Works
Caffevolve carries no inventory, no production liability, and no capital equipment costs. Partners manufacture at their existing scale and capability.
A single technology platform can be licensed simultaneously to multiple manufacturers across global markets, multiplying revenue without multiplying costs.
Patent-pending status creates a defensible moat. Partners gain exclusivity windows; Caffevolve retains ownership of the underlying technology.
The premium coffee equipment market rewards innovation. Partners are actively seeking differentiation to justify premium price points and drive new consumer adoption.
Partner Value Proposition
The blend-then-grind system has been engineered, prototyped, and technically validated across all three product tiers with documented performance specifications.
Provisional patent filed February 2026 establishes priority. Partners acquire a protected technology advantage, not a commodity feature.
Three distinct product tiers — Originara, Advancara, and Culminara — allow partners to deploy across entry, premium, and commercial segments simultaneously.
No competitor offers precision blend-then-grind caffeine control. Founding license partners gain exclusivity windows before the patent opens to the broader market.
About Caffevolve™
Caffevolve™ Corporation is a coffee brewing technology startup headquartered in Kenosha, Wisconsin, operating on an asset-light IP licensing model. The company was founded on a simple but powerful insight: the coffee market had solved for taste, but never for control.
Our mission is to enable the world's leading appliance manufacturers to offer consumers something genuinely new — complete command over their caffeine intake without any compromise to the coffee experience they love.
We're not building coffee makers. We're building the platform that makes the next generation of coffee makers possible.
Brent conceived the Caffevolve™ platform after years of owning and operating a retail coffee business, an experience that gave him firsthand insight into the impact of the '3 PM dilemma' — the moment when caffeine sensitivity drives consumers away from coffee — and the persistent gap in the premium coffee equipment market that no manufacturer had yet addressed with the engineering precision required to solve it. He leads all technology development, patent strategy, and licensing initiatives for the company from Kenosha, Wisconsin.
Where We've Been & Where We're Going
Resources
Select the documents most relevant to your interest. All materials are confidential and intended for serious prospective partners and investors only.
Common Questions
No. Caffevolve™ operates a purely asset-light IP licensing model. We design, patent, and support the technology — our licensing partners handle all manufacturing, marketing, and distribution under their own established brand. You bring the production capability; we bring the patented innovation.
The Caffevolve™ license covers the complete Blend-Then-Grind™ technology platform: the dual-hopper proportional bean dispensing method, the dual-auger mechanism, the post-brew Flavor & Wellness additive dispensing system, and the software-driven caffeine scheduling architecture. You receive full engineering specifications, USPTO-compliant technical drawings, and ongoing IP portfolio support.
Caffevolve™ targets a 5–8% royalty rate on the wholesale price of each unit sold. Exact rates, exclusivity terms, territory rights, and minimum annual unit commitments are negotiable and will be formalized in a definitive licensing agreement. We are open to tiered structures that align with volume commitments.
The technology is fully specified and patent-pending with a positive search opinion received in February 2026. Complete engineering documentation and USPTO-compliant technical drawings are ready for review under NDA. Functional prototype development is a planned next step, funded through current investment activity.
Yes. Upon execution of a mutual NDA, Caffevolve™ provides a complete technical review package including all engineering specifications, system architecture documentation, USPTO-compliant drawings, and the full patent claim strategy. Contact Brent Langevin directly to initiate the NDA process.
Territory or category exclusivity is negotiable for founding licensing partners who move early. Caffevolve™ intends to pursue multiple non-exclusive licensees in parallel, so early partners who commit to minimum volume terms may have the opportunity to negotiate exclusivity protections. This is best discussed directly.
Caffevolve™ is a pre-revenue, pre-prototype seed-stage company with a fully developed patent-pending technology platform. In February 2026, we received a positive patentability opinion from Kaufold & Dix Patent Law confirming the novelty of all core innovations. Current investment funds the utility patent filing and initial prototype development.
The current pre-patent valuation is $2.5M, reflecting the provisional patent filing, comprehensive IP documentation, positive search opinion, and fully developed go-to-market strategy. Upon grant of the utility patent, independent research (PitchBook, Greenberg 2013, Farre-Mensa 2017) supports a projected post-patent valuation range of $8M–$12M. Full methodology is detailed in our Post-Patent Valuation Analysis.
Three structures are available at $25K, $50K, and $75K investment levels: a Convertible Note (6% interest, 24-month maturity, $2.5M cap, 20% discount — our recommendation), a SAFE Note (no interest, no maturity, same cap and discount), and Direct Equity (immediate 2.91% ownership at $75K). Full plain-language explanations of each are in the Investment Options Guide.
Investment funds four key activities: filing the full non-provisional utility patent through top-tier IP counsel ($20–$25K), building a functional prototype ($15–$20K), licensing outreach and business development including materials and trade show presence ($10–$15K), and trademark filings plus a 6–12 month operating reserve ($12–$18K).
The primary risks are: patent scope (the USPTO may grant narrower claims than filed), licensing execution (manufacturers may decline to license), market adoption (consumer demand may be lower than projected), and timing (patent prosecution typically takes 2–3 years). A full, unvarnished risk analysis including worst-case scenarios is included in the Investment Options Guide. We strongly recommend consulting your own legal and financial advisors before investing.
Conservative five-year projections assume 1.875M units through 2–6 manufacturing partners, generating $892M in partner revenue and $67.4M in Caffevolve™ royalties. At a $75K convertible note investment converting at the $2.5M cap in a scenario where the company reaches an $8M valuation, your ~$81,750 (with interest) could convert into approximately 3.2% ownership. All projections are forward-looking estimates and not guaranteed.
Preview not available in this browser.
↓ Download to view